Legal Medications Account for 90%, Including Prescription Sleep Aids and Anti-Anxiety Drugs

Experts Call for More Sophisticated Enforcement Standards

As police have strengthened penalties for drug-impaired driving, a review of actual cases shows that legal prescription medications are detected more frequently than illegal drugs. In particular, zolpidem, a medication used to treat insomnia, accounted for the highest proportion.


On April 5, Yonhap News Agency reported that, according to an analysis by a research team at the National Forensic Service of 1,046 suspected drug-impaired driving cases between 2023 and 2025, 55% of the detected substances were medical narcotics, while non-narcotic pharmaceuticals accounted for 41%.


Among medical narcotics, central nervous system depressants—used for inducing sleep and sedation—were the most common. Of these, zolpidem was detected in 370 cases over the three-year period, making it the most frequently found drug. The anti-anxiety drug alprazolam and the sleeping aid flunitrazepam followed with 144 and 126 cases, respectively. These medications can impair driving by causing drowsiness, slower reaction times, and decreased motor skills.


A traffic police officer conducting a drunk driving checkpoint. Photo by Yonhap News

A traffic police officer conducting a drunk driving checkpoint. Photo by Yonhap News

View original image

In the category of non-narcotic pharmaceuticals, antipsychotics and antidepressants represented the majority. Notably, quetiapine was detected in 108 cases, and a significant number of antihistamines were also identified. These medications, too, can cause drowsiness or reduced concentration, potentially affecting driving ability.


In contrast, illegal narcotics accounted for only 4% of the total. The detection rates were relatively low, with 28 cases of methamphetamine, 19 cases of cannabis, and 16 cases of synthetic cannabinoids.


Police emphasized that, to prevent drug-impaired driving, individuals must always verify whether it is safe to drive before taking any medication, and should refrain from driving for a certain period after consuming drugs that may cause drowsiness. They also clarified that enforcement targets not mere consumption, but driving while actual impairment in judgment or reaction is present.


Experts point out that simply detecting the presence of a substance is not sufficient to assess risk. The research team stated, "If factors such as drug tolerance, individual metabolic differences, and timing of intake are not considered, even therapeutic use may be mistaken for risky behavior." They added, "There is a need for more sophisticated standards that reflect the specific properties of each type of drug."



Currently, the police, together with related agencies, are conducting research to improve blood concentration thresholds and enforcement methods, with plans to establish more concrete standards.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing